Navigation Links
Bill Gates pours in funds for diarrhea treatment reseach

A San Francisco nonprofit pharmaceutical company was given $46 million to develop its research on innovative treatments to deal with diseases // which cause diarrhea which is incidently the main reason for the loss of lives of almost two million chiidren around the world.

The pharmaceutical company One World Health based in San Fransisco gets the grant for developing new drugs that would help to slow down fluid loss from the intestines. The conventional treatment for diarrhea involves rehydration to counter the loss of fluids from the body. Dehydration which is the immediate aftereffect of severe loose stools ,can be life threatening to both infants and young children. One World Health in their effort to develop more drugs which would curb fluid loss from gastro intestinal tract hopes to complement current treatment manifesto instead of opposing it.

One World will work with partners across the globe including the International Centre for Diarrheal Disease Research in Bangladesh it was revealed the Organization’s program director Sue Wilson.
MST
'"/>




Page: 1

Related medicine news :

1. Bill Gates to Fund ￡28m for Malaria researc
2. Bill Gates Takes Personal Interest in AIDS Program
3. Dr.Tadataka Yamada Designated to open Gates for Global Health Program
4. Gates Foundation to donate USD 104 million to TB Alliance
5. Bill Gates Clarifies that his Decision to Focus on Charity was Personal
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. Gates Foundation Adopts Fight against Encephalitis
8. Clinton, Gates Highlight Treatment, Discrimination of AIDS
9. $68 million aid pours in from Gates Foundation to fight tropical diseases
10. Gates Foundation Grants $23mn for AIDS programme in India
11. Gates Foundation Pledges $3 Million to Fight Malaria in Africa
Post Your Comments:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
... follows weight pattern in France reveals that Fre...and fatter//. According to the ObEpi-Roche survey...5 years is affected by weight problem, with 1/3rd ... obese.Obesity is on a high in France, in spite of...
...the next school year will probably see a promotion...le to apply for a chunk// of a $3-million-a-year N... $12 million Nutrition Fund as part of its support... Government. Schools and early childhood centers...
...earchers suggest a short-term application of topic...ent agent for patients// with intertriginous psori...eptember issue of Archives of Dermatology, one of ... is an inflammatory skin disease. In a subset of ...
...researchers at Manchester University, hearing voic...ses the traditional belief//. A Dutch report revea...n fact, several people who hear voices do not seek... voice has a positive effect on them by calming or...
Other Medicine News:Health News:Obesity on a high in France 2Health News:Better Nutrition in Schools Boosted by $12m Fund 2Health News:Short-Term Topical Corticosteroid May Offer Relief for Certain Type of Psoriasis 2Health News:Hearing voices may be normal 2
(Date:10/9/2008)...al Results Expected in November 2008, BOTHELL, Wa..., Inc.,(Amex: DDD ) announced today the completio...f its three pivotal trials to evaluate the safety ...d-release (ER) ibuprofen for,the over-the-counter ...ne,results from this pivotal trial in November 200...
(Date:10/8/2008)...Someday Inform Treatments for Spinal Cord, Other N...-USNewswire/ -- A protein that enables,nerve cells...n controlling,the developing nervous system. Resea...s to form among nerve cells may provide a basis fo...ries to their nervous system,including spinal cor...
(Date:10/8/2008)...Confirm Potency of Poly-ICR as Vaccine Adjuvant, ... Biopharmaceuticals,Corporation (TSX: NVN) today p...ing its proprietary Toll-like Receptor 3 agonist, ...cine Congress 2008 in Lyon, France.,Study results ...ant,targeting the Toll-like Receptor 3 (TLR3) path...
(Date:10/7/2008)... efficacy of new device for detecting polyps that ...copy, ORLANDO, Fla., Oct. 7 /- At th...ntific Meeting in Orlando (ACG 2008), renowned,gas...ts from a,multi-institutional clinical study that ...ope(R), a new device that is designed to improve t...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Preeclampsia Linked to Heart Disease Risk 5393 1Preeclampsia Linked to Heart Disease Risk 5393 2Preeclampsia Linked to Heart Disease Risk 5393 3Cornell will host the Northeast Biofuel Summit Nov 11 13 1087 1Mannatech Hosts Australasian Convention 5389 1Mannatech Hosts Australasian Convention 5389 2Mannatech Hosts Australasian Convention 5389 3American Medical Womens Association Supports New Bill That Requires Medicare Coverage of HPV Testing as Part of Cervical Cancer Screening 5386 1American Medical Womens Association Supports New Bill That Requires Medicare Coverage of HPV Testing as Part of Cervical Cancer Screening 5386 2American Medical Womens Association Supports New Bill That Requires Medicare Coverage of HPV Testing as Part of Cervical Cancer Screening 5386 3
... 8, 2007 - Late-breaking Phase III,clinical trial ...ety on Thrombosis and Haemostasis (ISTH) Congress ...uperior efficacy in the,prevention of venous throm...cement surgery in a head-to-head comparison with,e...in the RECORD3,(REgulation of Coagulation in major...
...ess with Positive Phase IIa Clinical,Trial Results...lication of Key,Product in AM-Pharma,s Pipeline , ...V., the,biopharmaceutical company developing novel... diseases, today announced the positive,clinical r...trial,for patients with ulcerative colitis, a chro...
Other Medicine Technology:Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 2AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 3AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 4AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 5
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: